SOURCE: Industrial Biotechnology Corp.

March 20, 2007 15:16 ET

Industrial Biotechnology Corporation to Attend and Present at the Fourth Annual World Congress on Industrial Biotechnology and Bioprocessing

SARASOTA, FL -- (MARKET WIRE) -- March 20, 2007 -- Industrial Biotechnology Corporation (PINKSHEETS: IBTY) (IBC), a company dedicated to new biotechnologies and innovations in the chemical industry, today announced that members of its Senior Scientific and Management Team will be attending The Fourth Annual World Congress on Industrial Biotechnology and Bioprocessing in Orlando, Florida on March 21-24.

The World Congress on Industrial Biotechnology and Bioprocessing is the premiere gathering of thought leaders, investors, researchers and business executives in industrial biotechnology, bioenergy and bioprocessing. The conference will provide IBC an opportunity to showcase its proprietary and licensed technologies, including the recently announced ALCHEMx Bio Renewable Production Platform™; a proprietary bioprocesses to convert ethanol into various chemical feedstock compounds.

"During this conference, we will be discussing IBC's ethanol related and derivative technologies as well as our existing biotechnologies and proprietary ALCHEMx Production Platforms. We will be looking to forge and enhance relationships and partnerships with companies that possess complimentary technologies or capabilities in order to jointly capitalize on a rapidly growing bio-renewable chemicals market," said Gary Howell, VP Business Development and Scientific Operations.

IBC will be presenting its biotechnologies and conducting exploratory meetings with potential business partners, peers, investors and industry media throughout the conference dates. Interested parties are encouraged to contact IBC in advance of the conference to pre-set specific meeting times.

About Industrial Biotechnology Corporation

Industrial Biotechnology Corporation (IBC) enables the biological production of chemicals through a combination of licensed patents, intellectual property and proprietary systems. We accomplish this through our ALCHEMx™ Productions Platforms, which are a systematic, streamlined approach to biologically manufacture chemicals more efficiently, at significantly lower costs, and with substantially lower environmental impact than traditional methods. IBC and its partners plan to produce and market new and established biologically produced chemicals to the pharmaceutical, bio-energy, agricultural, biopesticides, fine chemicals, flavors and fragrances, cosmeceuticals, biomaterials and biopolymer industries. For more information about Industrial Biotechnology Corporation, please visit its website at www.industrialbiotechnology.com.

Forward-Looking Statements

Certain matters discussed in this press release are "forward-looking statements." These forward-looking statements can generally be identified as such because the context of the statement will include words such as "expects," "should," "believes," "anticipates" or words of similar import. Similarly, statements that describe Industrial Biotechnology Corporation's future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of Industrial Biotechnology Corporation, as appropriate, which could cause actual results to differ materially from those currently anticipated. Although Industrial Biotechnology Corporation believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, they cannot give any assurance that their expectations will be attained. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating any forward-looking statements. Certain factors could cause results and conditions to differ materially from those projected in these forward-looking statements, and some of these factors are discussed below. These factors are not exhaustive. New factors, risks and uncertainties may emerge from time to time that may affect the forward-looking statements made herein. These forward-looking statements are only made as of the date of this press release and Industrial Biotechnology Corporation does not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Contact Information

  • Contact:
    Investor Relations
    Industrial Biotechnology Corporation
    2033 Main Street
    Suite 400
    Sarasota, FL 34237
    941-925-2500 phone
    941-925-2503 fax